Inventor profile of:

Seng CHENG

City:

Natick, Massachusetts

Country:

United States

Published Applications:

16

Last publication date:

2026-06-18

Top Assignees for applications by Seng CHENG

The entities that hold a legal rights for patent applications filed by inventor CHENG Seng:

Recent patent applications by CHENG Seng

Seng CHENG from Natick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18
US20260167645A1
Chemistry; metallurgy

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#2 | 2026-04-30
US20260115165A1
Human necessities

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#3 | 2025-08-21
US20250263685A1
Chemistry; metallurgy

OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF

#4 | 2021-12-23
US20210393590A1
Human necessities

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#5 | 2021-12-02
US20210369672A1
Human necessities

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#6 | 2021-08-26
US20210261557A1
Chemistry; metallurgy

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#7 | 2020-02-13
US20200048266A1
Chemistry; metallurgy

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#8 | 2016-07-21
US20160207933A1
Chemistry; metallurgy

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#9 | 2016-06-16
US20160166542A1
Human necessities

Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase

#10 | 2016-05-05
US20160120842A1
Human necessities

AMORPHOUS AND A CRYSTALLINE FORM OF GENZ 112638 HEMITARTRATE AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE

#11 | 2015-10-08
US20150284472A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES

#12 | 2015-08-27
US20150238627A1
Human necessities

Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy

#13 | 2014-12-18
US20140371460A1
Chemistry; metallurgy

Glucosylceramide synthase inhibitors

#14 | 2014-09-11
US20140255381A1
Chemistry; metallurgy

Glucosylceramide synthase inhibitors

#15 | 2013-05-30
US20130137743A1
Chemistry; metallurgy

Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase

#16 | 2009-05-07
US20090117156A1
Chemistry; metallurgy

GENE THERAPY FOR NIEMANN-PICK DISEASE TYPE A

InventorID:

903490 ⎘